Enzolytics, Inc. (OTCMKTS:ENZC) Short Interest Update

Enzolytics, Inc. (OTCMKTS:ENZC) was the recipient of a significant decline in short interest in December. As of December 15th, there was short interest totalling 200 shares, a decline of 99.9% from the November 30th total of 291,200 shares. Based on an average daily trading volume, of 34,938,700 shares, the days-to-cover ratio is currently 0.0 days.

Enzolytics Stock Up 12.5 %

ENZC traded up $0.00 during trading on Friday, hitting $0.00. The company had a trading volume of 7,346,088 shares, compared to its average volume of 11,030,960. Enzolytics has a one year low of $0.00 and a one year high of $0.02.

Enzolytics Company Profile

Enzolytics Inc, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy.